|
Acetyl Angiotensinogen (1-14), porcine
|
AC-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-LEU-VAL-TYR-SER
|
66641-26-7
|
|
Ac-Arg-Cys-Met-5-aminopentanoyl-Arg-Val-Tyr-5-aminopentanoyl-Cys-NH2
|
AC-ARG-CYS-MET-5-AMINOPENTANOYL-ARG-VAL-TYR-5-AMINOPENTANOYL-CYS-NH2
|
|
|
AC-ARG-OME HCL
|
AC-ARG-OME HCL
|
1784-05-0
|
|
Acetalin 1, Opioid Receptor Antagonist 1;Ac-RFMWMR-NH2
|
AC-ARG-PHE-MET-TRP-MET-ARG-NH2
|
152274-65-2
|
|
Abz-Phe-Arg-Lys(Dnp)-Pro-OH
|
ABZ-PHE-ARG-LYS(DNP)-PRO-OH
|
500799-61-1
|
|
ABZ-PHE-ARG-PHE(NO2)-OH
|
ABZ-PHE-ARG-PHE(NO2)-OH
|
|
|
ABZ-PHE-ARG-SER-ARG-GLN-EDDNP
|
ABZ-PHE-ARG-SER-ARG-GLN-EDDNP
|
|
|
Abz-Ser-Pro-3-nitro-Tyr-OH
|
ABZ-SER-PRO-3-NITRO-TYR-OH
|
553644-01-2
|
|
Abz-tBu-Gly-tBu-Gly-Asn(Me)2-Ala-Ser-Ser-Arg-Leu-3-nitro-Tyr-Arg-OH
|
ABZ-TBU-GLY-TBU-GLY-ASN(ME)2-ALA-SER-SER-ARG-LEU-3-NITRO-TYR-ARG-OH
|
204909-37-5
|
|
Ac-5A/5B Peptide;Ac-EDVVCCSMSY-NH2
|
AC-GLU-ASP-VAL-VAL-CYS-CYS-SER-MET-SER-TYR-NH2
|
|
|
Ac-[Nle4, D-Phe7]-α-MSH (4-10), amide;Ac-Nle-EHfRWG-NH2
|
AC-NLE-GLU-HIS-D-PHE-ARG-TRP-GLY-NH2
|
|
|
Acetyl, a-Endorphin
|
AC-TYR-GLY-GLY-PHE-MET-THR-SER-GLU-LYS-SER-GLN-THR-PRO-LEU-VAL-THR
|
|
|
Ac-(6-O-stearoyl)-muramyl-Ala-D-Glu-NH2
|
AC-(6-O-STEAROYL)-MURAMYL-ALA-D-GLU-NH2
|
|
|
Ac, b-Endorphin: 1-27, camel, bovine, ovine
|
AC-TYR-GLY-GLY-PHE-MET-THR-SER-GLU-LYS-SER-GLN-THR-PRO-LEU-VAL-THR-LEU-PHE-LYS-ASN-ALA-ILE-ILE-LYS-ASN-ALA-HIS: AC-YGGFMTSEKSQTPLVTLFKNAIIKNAH
|
|
|
Acetyl-GRP (20-27) (human, porcine, canine)
|
AC-HIS-TRP-ALA-VAL-GLY-HIS-LEU-MET-NH2
|
77714-20-6
|
|
Ac-d-Endorphin (bovine, camel, mouse, ovine)
|
AC-TYR-GLY-GLY-PHE-MET-THR-SER-GLU-LYS-SER-GLN-THR-PRO-LEU-VAL-THR-LEU-PHE-LYS-ASN-ALA-ILE-ILE-LYS-ASN-ALA-HIS
|
|
|
Acetyl-(Asn30,Tyr32)-Calcitonin (8-32) (salmon I)
|
AC-VAL-LEU-GLY-LYS-LEU-SER-GLN-GLU-LEU-HIS-LYS-LEU-GLN-THR-TYR-PRO-ARG-THR-ASN-THR-GLY-SER-ASN-THR-TYR-NH2
|
151804-77-2
|
|
Acetyl-(Cys(Acm)33·42)-EGF (33-42) amide (mouse)
|
AC-CYS(ACM)-VAL-ILE-GLY-TYR-SER-GLY-ASP-ARG-CYS(ACM)-NH2
|
|
|
Ac-[Tyr1,D-Arg2]-GRF (1-29) amide (human)
|
AC-TYR-DARG-ASP-ALA-ILE-PHE-THR-ASN-SER-TYR-ARG-LYS-VAL-LEU-GLY-GLN-LEU-SER-ALA-ARG-LYS-LEU-LEU-GLN-ASP-ILE-MET-SER-ARG-NH2
|
93942-91-7
|
|
Acetyl-(D-Lys2,Sar3)-Melanotropin-Potentiating Factor
|
AC-LYS-D-LYS-SAR-GLU
|
81483-91-2
|
|
Ac-[DTrp16] Endothelin-1 (16-21), human
|
AC-D-TRP-LEU-ASP-ILE-ILE-TRP
|
143037-33-6
|
|
Acetyl-(Leu28·31)-Neuropeptide Y (24-36)
|
AC-LEU-ARG-HIS-TYR-LEU-ASN-LEU-LEU-THR-ARG-GLN-ARG-TYR-NH2
|
155709-24-3
|
|
Acetyl-Lys0,Nle3-g2-MSH amide
|
AC-LYS-TYR-VAL-NLE-GLY-HIS-PHE-ARG-TRP-ASP-ARG-PHE-GLY-NH2
|
237761-41-0
|
|
Acetyl [Pro18, Asp21] beta-Amyloid (17-21), amide, iAb5p Pro18 Asp21;Ac-LPFFD-NH2
|
AC-LEU-PRO-PHE-PHE-ASP-NH2
|
339990-02-2
|
|
Ac-a-CGRP (19-37) (human)
|
AC-SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
|
145459-34-3
|
|
Acetyl-ACTH (1-14)
|
AC-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY
|
|
|
N-Acetyl, ACTH (1-17), human
|
AC-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG
|
197906-63-1
|
|
Acetyl-Adhesin (1025-1044) amide
|
AC-GLN-LEU-LYS-THR-ALA-ASP-LEU-PRO-ALA-GLY-ARG-ASP-GLU-THR-THR-SER-PHE-VAL-LEU-VAL- NH2
|
320350-56-9
|
|
Ac-Ala-Ala-Ala-Ala-OH
|
AC-ALA-ALA-ALA-ALA-OH
|
15483-58-6
|
|
Ac-Ala-Ala-Ala-Ala-OMe
|
AC-ALA-ALA-ALA-ALA-OME
|
30802-29-0
|
|
Ac-Ala-Ala-Ala-OH
|
N-乙?；?L-丙氨酰-L-丙氨酰-L-丙氨酸
|
19245-85-3
|
|
Ac-Ala-Ala-Ala-OMe
|
N-乙?；?L-丙氨?；?L-丙氨?；?L-丙氨酸甲酯
|
26910-17-8
|
|
Ac-Ala-Ala-Ala-pNA
|
AC-ALA-ALA-ALA-PNA
|
40817-33-2
|
|
Ac-Ala-Ala-OH
|
AC-ALA-ALA-OH
|
19245-87-5
|
|
Ac-Ala-Ala-OMe
|
AC-ALA-ALA-OME
|
30802-26-7
|
|
Ac-Ala-Ala-Phe-OMe
|
AC-ALA-ALA-PHE-OME
|
50395-42-1
|
|
Ac-Ala-Ala-Pro-Ala-AMC
|
AC-ALA-ALA-PRO-ALA-AMC
|
62037-45-0
|
|
Ac-Ala-Ala-Pro-Ala-pNA
|
AC-ALA-ALA-PRO-ALA-PNA
|
96699-74-0
|
|
Ac-Ala-Ala-Pro-Phe-pNA
|
AC-ALA-ALA-PRO-PHE-PNA
|
70967-94-1
|
|
Ac-Ala-Ala-Pro-Val-pNA
|
AC-ALA-ALA-PRO-VAL-PNA
|
133261-53-7
|
|
Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH
|
ABZ-GLY-ILE-VAL-ARG-ALA-LYS(DNP)-OH
|
827044-38-2
|
|
Abz-Gly-p-nitro-Phe-Pro-OH
|
血管緊張素轉(zhuǎn)化酶底物
|
67482-93-3
|
|
Abz-Leu-Ala-Gln-Ala-Val-Arg-Ser-ser-Ser-Arg-Dap: Dnp-NH2
|
ABZ-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-DAP: DNP-NH2
|
|
|
Abz-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2
|
ABZ-LYS-PRO-LEU-GLY-LEU-DAP(DNP)-ALA-ARG-NH2
|
290362-09-3
|
|
ABZ-PHE-ARG-ALA-EDDNP
|
ABZ-PHE-ARG-ALA-EDDNP
|
|
|
ABZ-PHE-ARG-ARG-EDDNP
|
ABZ-PHE-ARG-ARG-EDDNP
|
|
|
ABZ-PHE-ARG-LEU-EDDNP
|
ABZ-PHE-ARG-LEU-EDDNP
|
|
|
Acetyl-(D-Val13)-α-MSH (11-13)
|
ACETYL-(D-VAL13)-Α-MSH (11-13)
|
|
|
Ac-MBP (4-14) Peptide
|
ACETYL-(GLN4)-MYELIN BASIC PROTEIN (4-14)
|
|
|
Acetyl-(Lys0,Nle3)-γ2-MSH amide
|
ACETYL-(LYS0,NLE3)-Γ2-MSH AMIDE
|
|
|
Acetyl-(D-Trp1,4-chloro-D-Phe2,D-Trp3,D-Arg6,D-Ala10)-LHRH
|
ACETYL-(D-TRP1,4-CHLORO-D-PHE2,D-TRP3,D-ARG6,D-ALA10)-LHRH
|
86044-76-0
|
|
Acetyl-(D-Lys11,D-Val13)-α-MSH (11-13)
|
ACETYL-(D-LYS11,D-VAL13)-Α-MSH (11-13)
|
|
|
Acetyl-(3,4-dehydro-Pro1,4-fluoro-D-Phe2,D-Trp3·6)-LHRH
|
ACETYL-(3,4-DEHYDRO-PRO1,4-FLUORO-D-PHE2,D-TRP3·6)-LHRH
|
78708-43-7
|
|
Acetyl-(Ala10·11)-RANTES (1-14) amide (human)
|
ACETYL-(ALA10·11)-RANTES (1-14) AMIDE (HUMAN)
|
838825-26-6
|
|
BQ-3020
|
BQ-3020
|
143113-45-5
|
|
Acetyl-(Cys11,D-2-Nal14,Cys18)-β-MSH (11-22) amide
|
ACETYL-(CYS11,D-2-NAL14,CYS18)-Β-MSH (11-22) AMIDE
|
|
|
Acetyl-(Cys3,Nle4,Arg5,D-2-Nal7,Cys11)-α-MSH (3-11) amide
|
ACETYL-(CYS3,NLE4,ARG5,D-2-NAL7,CYS11)-Α-MSH (3-11) AMIDE
|
|
|
Acetyl-(Cys4,D-Phe7,Cys10)-α-MSH (4-13)
|
ACETYL-(CYS4,D-PHE7,CYS10)-Α-MSH (4-13)
|
|
|
Acetyl-(D-Arg10,Cys11,D-Phe14,Cys17)-β-MSH (10-17) amide
|
ACETYL-(D-ARG10,CYS11,D-PHE14,CYS17)-Β-MSH (10-17) AMIDE
|
|
|
Acetalin 2, Opioid Receptor Antagonist 2;Ac-RFMWMK-NH2
|
AC-ARG-PHE-MET-TRP-MET-LYS-NH2
|
152274-66-3
|
|
Acetalin 3, Opioid Receptor Antagonist 3;Ac-RFMWMT-NH2
|
AC-ARG-PHE-MET-TRP-MET-THR-NH2
|
152274-67-4
|
|
Ac-RYYRIK-NH2
|
AC-ARG-TYR-TYR-ARG-ILE-LYS-NH2
|
200959-48-4
|
|
α-Casein (90-95)
|
ARG-TYR-LEU-GLY-TYR-LEU
|
83471-50-5
|
|
Ac-Asp(Glu-OH)-OH
|
司谷氨酸
|
4910-46-7
|
|
Ac-Asp-Arg-Gly-Asp-Ser-OH
|
AC-ASP-ARG-GLY-ASP-SER-OH
|
151997-55-6
|
|
Ac-Asp-Arg-Leu-Asp-Ser-OH
|
AC-ASP-ARG-LEU-ASP-SER-OH
|
153959-57-0
|
|
Ac-Asp-DGla-Leu-Ile-b-cyclohexyl-Ala-Cys
|
AC-ASP-DGLA-LEU-ILE-CHA-CYS
|
208940-40-3
|
|
Ac-Asp-Glu-OH
|
異冬谷酸
|
3106-85-2
|
|
Ac-Asp-Glu-Asp(EDANS)-Glu-Glu-Abu-L-lactoyl-Ser-Lys(DABCYL)-NH2
|
AC-ASP-GLU-ASP(EDANS)-GLU-GLU-ABU-L-LACTOYL-SER-LYS(DABCYL)-NH2
|
188530-20-3
|
|
Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid)
|
半胱胺酸蛋白酶-10(抗體)
|
184179-08-6
|
|
Caspase 3 (Apopain) Substrate 1, chromogenic;Ac-DEVD-pNA
|
AC-ASP-GLU-VAL-ASP-PNA
|
189950-66-1
|
|
Caspase 3 Substrate 1m, fluorogenic;Ac-DMQD-AMC
|
AC-ASP-GLU-VAL-ASP-7-氨基-4-甲基香豆素
|
169332-61-0
|
|
Ac-Asp-Thr-Glu-Asp-Val-Val-Pro-DL-Nva-4-phenylazophenyl ester
|
AC-ASP-THR-GLU-ASP-VAL-VAL-PRO-DL-NVA-4-PHENYLAZOPHENYL ESTER
|
|
|
Ac-Asp-Tyr: 2-malonyl-Val-Pro-Met-Leu-NH2
|
AC-ASP-TYR(2-MALONYL)-VAL-PRO-MET-LEU-NH2
|
168135-79-3
|
|
SH2 Domain Ligand (1);Ac-D-pY-VPML-NH2
|
AC-ASP-TYR(PO3H2)-VAL-PRO-MET-LEU-NH2
|
157382-69-9
|
|
Ac-Calpastatin (184-210) (human)
|
乙酰鈣蛋白酶抑制蛋白(184-210)(人)
|
123714-50-1
|
|
Ac-Choline Receptor α1(129-145)
|
GLU-ILE-ILE-VAL-THR-HIS-PHE-PRO-PHE-ASP-GLU-GLN-ASN-CYS-SER-MET-LYS
|
|
|
Ac-Cys(farnesyl)-Val-Ile-Met-OH
|
AC-CYS(FARNESYL)-VAL-ILE-MET-OH
|
144608-65-1
|
|
Ac-D-E
|
AC-ASP-GLU
|
|
|
Ac-DEVD-CMK
|
AC-ASP-GLU-VAL-ASP-CMK: AC-DEVD-CMK
|
285570-60-7
|
|
Ac-D-Phe-Tyr-OH
|
AC-D-PHE-TYR-OH
|
73942-36-6
|
|
Ac-Endothelin-1 (16-21), human
|
AC-HIS-LEU-ASP-ILE-ILE-TRP
|
|
|
S-G-Q-S-W-R-P-Q-G-R-F, amide
|
ACEP-1
|
127122-98-9
|
|
Acetyl Gastric Inhibitory Peptide (human)
|
AC-TYR-ALA-GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN
|
|
|
Acetyl-(Nle4,Asp5,D-2-Nal7,Lys10)-cyclo-α-MSH (4-10) amide
|
ACETYL-(NLE4,ASP5,D-2-NAL7,LYS10)-CYCLO-Α-MSH (4-10) AMIDE
|
|
|
Acetyl-(Nle4,Asp5,D-Phe7,Lys10)-cyclo-α-MSH (4-10) amide
|
ACETYL-(NLE4,ASP5,D-PHE7,LYS10)-CYCLO-Α-MSH (4-10) AMIDE
|
|
|
Acetyl-Nle4,Asp5,DTyr7,Lys10-cyclo-a-MSH: 4-10 amide
|
AC-NLE-C(-ASP-HIS-DTYR-ARG-TRP-LYS-NH2)
|
213314-49-9
|
|
Acetyl-(Nle4,Asp5,D-Tyr7,Lys10)-cyclo-α-MSH (4-10) amide
|
ACETYL-(NLE4,ASP5,D-TYR7,LYS10)-CYCLO-Α-MSH (4-10) AMIDE
|
|
|
Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-α-MSH (4-10) amide
|
ACETYL-(NLE4,GLN5,D-PHE7,D-TRP9)-Α-MSH (4-10) AMIDE
|
|
|
Ac-Ala-Ala-Ser(PO3H2)-Pro-Arg-pNA
|
AC-ALA-ALA-SER(PO3H2)-PRO-ARG-PNA
|
202739-37-5
|
|
Ac-Ala-Ala-Tyr-AMC
|
AC-ALA-ALA-TYR-AMC
|
99590-93-9
|
|
Ac-Ala-Gln-Ala-pNA
|
AC-ALA-GLN-ALA-PNA
|
201677-60-3
|
|
Ac-Ala-Glu-OH
|
AC-ALA-GLU-OH
|
57282-74-3
|
|
Ac-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2
|
AC-ALA-LEU-CYS-ASP-ASP-PRO-ARG-VAL-ASP-ARG-TRP-TYR-CYS-GLN-PHE-VAL-GLU-GLY-NH2
|
|
|
Ac-Ala-Pro-Ala-pNA
|
AC-ALA-PRO-ALA-PNA
|
61596-39-2
|
|
Ac-Ala-Ser-Thr-Asp-AMC
|
AC-ALA-SER-THR-ASP-AMC
|
354151-60-3
|
|
Acetyl-Amylin (8-37) (human)
|
AC-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2
|
178603-79-7
|
|
Acetyl-Amylin (8-37), rat;Ac-ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2
|
AC-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-ARG-SER-SER-ASN-ASN-LEU-GLY-PRO-VAL-LEU-PRO-PRO-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2
|
|
|
Acetyl-beta-Amyloid (15-20);Ac-QKLVFF
|
AC-GLN-LYS-LEU-VAL-PHE-PHE- NH2
|
189064-06-0
|
|
Acetyl, Angiotensinogen (1-14), human
|
AC-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-ASN
|
104180-27-0
|